In addition, to test the hypothesis that HLA-B HED might be a potential germline genomic determinant for predicting the response to immunotherapy, we examined the prognostic effect of HLA-B HED in the MSK GI cohort. Here, HLA-B is linked to hypohidrotic ectodermal dysplasia.